Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 6/22/2025

Allergic Reactions to Rosuvastatin

Introduction to Allergic Reactions

  • True allergic reactions (IgE-mediated) to rosuvastatin can occur rapidly after exposure, with mild reactions including skin manifestations, and moderate-to-severe reactions including respiratory compromise, hypotension, and gastrointestinal symptoms, according to the American Academy of Pediatrics 1
  • Biphasic reactions to rosuvastatin can occur up to 72 hours after the initial reaction, as reported by the American Academy of Allergy, Asthma, and Immunology 1, 2
  • Serum sickness-like reactions to rosuvastatin may develop days after exposure, as noted by the American Academy of Allergy, Asthma, and Immunology 3

Patient Risk Factors

  • Patients with previous drug allergies are at higher risk for developing allergic reactions to rosuvastatin, as stated by the National Comprehensive Cancer Network 4
  • Patients taking concurrent medications that may interact with rosuvastatin are also at higher risk for developing allergic reactions, according to the American Heart Association 5

Management of Allergic Reactions

  • Grade 1 reactions (cutaneous symptoms only) to rosuvastatin may resolve with discontinuation of the medication, as reported by the American Academy of Allergy, Asthma, and Immunology 3
  • Grade 2-4 reactions to rosuvastatin require immediate medical attention and may need treatment with antihistamines, corticosteroids, or epinephrine, as stated by the American Academy of Allergy, Asthma, and Immunology 3

Prevention and Education

  • Patients should be advised to monitor for symptoms of allergic reactions, particularly within the first 24-72 hours after starting rosuvastatin, as recommended by the American College of Cardiology
  • Patients who experience an allergic reaction to rosuvastatin should not be rechallenged with the same medication unless under specialist supervision, as suggested by the American College of Cardiology 3

REFERENCES

2

allergen immunotherapy: a practice parameter third update. [LINK]

Journal of Allergy and Clinical Immunology, 2011

3

drug allergy: a 2022 practice parameter update. [LINK]

Journal of Allergy and Clinical Immunology, 2022

4

epithelial ovarian cancer. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2011

5

drug interactions affecting oral anticoagulant use. [LINK]

Circulation: Arrhythmia and Electrophysiology, 2022